Authored by Zachary Stieber via The Epoch Times, The Food and Drug Administration on Aug. 27 approved COVID-19 vaccines from Pfizer, Moderna, and Sanofi. The new shots from Pfizer and […]
What you need to know about updated COVID vaccines following FDA approval
ByYouri Benadjaoud, Mary Kekatos, and Ava Tsapatsaris As summer winds down and children and teenagers across the U.S. head back to school, it also means updated COVID-19 vaccines are around the corner. […]
Flatten the curve meant prolong the pain
The real reason for all of it was to “delay the onset of natural immunity Brownstone Institute, @brownstoneinst Jeffrey Tucker just revealed that top FDA and NIH quietly admitted the […]
Multidisciplinary Care Pathways for Long COVID Fatigue:
A Systems-Based Model Integrating Rehabilitation Medicine, Neuroimmunology, Autonomic Care, and Precision Phenotyping Abstract Background Long COVID, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), has emerged as one […]
Long COVID and Persistent Pulmonary Dysfunction: Emerging Evidence for Chronic Respiratory Sequelae, Pulmonary Pathology, and Dyspnea
John Murphy, President COVID-19 Long-haul Foundation Abstract Long COVID, also termed post-COVID condition or post-acute sequelae of SARS-CoV-2 infection (PASC), continues to represent one of the most consequential chronic disease […]
Long COVID and Dysautonomia: Emerging Insights Into Autonomic Dysfunction, Vagal Pathobiology, Neuroimmune Interactions, and Therapeutic Strategies
John Murphy, M.D., M.P.H., D.P.H. CEO COVID Long-haul Foundation Abstract Background Long COVID, also termed Post-Acute Sequelae of SARS-CoV-2 Infection (PASC), is a complex multisystem disorder characterized by persistent symptoms […]
NIH RECOVER Clinical Trials and the First Emergence of Interventional Results in Long COVID Research: A Translational Turning Point
A Scholarly Review for Scientific American (Submission-Style Manuscript) John Murphy, M.D., M.P.H., D.P.H., President, COVID-19 Long-Haul Foundation Abstract The NIH RECOVER Initiative represents the largest coordinated research program investigating post–acute […]
Treatment Landscape in Long COVID Has Expanded Beyond “Supportive Care”
A Mechanism-Driven Reframing of Therapeutic Development in Post–Acute SARS-CoV-2 Disease John Murphy, M.D, M.P.H., D.P.H. President COVID Long-haul Foundation Conceptual Shift and Therapeutic Reclassification ABSTRACT For much of the early […]
Long COVID–Associated Vertigo: Etiology, Pathophysiology, Clinical Course, and Therapeutic Strategies
John Murphy, CEO The COVID-19 Long-haul Foundation Introduction Persistent vertigo and disequilibrium have emerged as prominent neurological sequelae of post-acute SARS-CoV-2 infection, commonly termed long COVID. While early pandemic focus […]
Pharmacologic Management of Long COVID: Mechanisms, Therapeutics, Risks, and Emerging Clinical Trials
John Murphy, CEO, The Covid-Long haul Foundation Abstract Long COVID (Post-Acute Sequelae of SARS-CoV-2 infection, PASC) is a heterogeneous, multi-system disorder characterized by persistent symptoms following acute infection. Affecting tens […]